{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/8cf4cec7-5a0f-49c5-8ec9-36941b5c6b6e/02842883-fa7a-4306-95db-f83d7e300e8d?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Genomic Prediction’s Elizabeth Carr: “Scoring embryos”","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba0b311a8cbef1d93cf121/1786085133474-44cb5d27-a02c-435b-aac9-2942140bfbc9.jpeg?height=200","description":"<p>The Sunday Times’ tech correspondent Danny Fortson brings on Elizabeth Carr, America’s first baby conceived by in-vitro fertilization and patient advocate at Genomic Prediction, to talk about the new era of pre-natal screening (5:45), the dawn of in-vitro fertilization (8:40), the technology’s acceptance (12:10), what Genomic Prediction does (13:40), scoring embryos (16:30), the slippery slope (19:20), selecting for smarts (24:15), the cost (25:00), and the future of conception (28:30). <strong>PLUS</strong> Dan Benjamin, bio economist at UCLA, comes on to talk about why he and others raised the alarm about polygenic scoring (30:20), drawing the line between prevention and enhancement (34:15), limits of the tech (37:15), what else we can select for (40:00), and unexpected consequences (42:00).</p>","author_name":"The Sunday Times"}